A Virtual Discussion Moderated by Personalized Medicine Coalition Founder Geoffrey S. Ginsburg
April 22, 2021 | 10:00 - 11:30 a.m. ET
Center Training Program Empowers Genetic Counselors in Research
Editor’s note: This is one in a series of first-person essays by members of the Duke community reflecting on a year living with COVID-19.
Clinicians have historically used family health history collection as a primary method for identifying actionable disease-risk assessments.
Deepak Voora, MD, represents the Department of Veterans Affairs in an American Medical Association panel discussion covering diverse perspectives o
Geoffrey Ginsburg has received a supplemental award to the IGNITE II Coordinating Center: Engagement, Coordination, Demonstration, and Dissemination to provide support to the NHGRI Training Modules in Genomic Medicine program.
Geoffrey Ginsburg has received a sub-award (NNJ15HK11B) through KBRwyle for a project entitled "One-Carbon Metabolism Genetics Data Analyses."
Ryan Shaw and Ph.D. student Anna Diane received an award for Diane's NIH/NINR NRSA Fellowship proposal "Engaging Black Men in Digital Health to Improve Self-Management of Type 2 Diabetes: An Iterative Participatory Design Approach."
The Enabling Precision Health and Medicine Bass Connections team, led by Susanne Haga, has been renewed for the 2020-2021 school year.
Lori Orlando, along with a team at Vanderbilt, was awarded a NIH Moonshot grant focused on boosting hereditary cancer identification. The team will use MeTree to collect and analyze family health history.
CAGPM faculty and staff showed that the transcriptome in peripheral blood reveals unique aspects of the immune response in COVID-19 and provides for novel biomarker-based approaches to diagnosis.
CAGPMers monitored Duke students and close contacts who developed respiratory tract infection symptoms, demonstrating transcriptomal biomarkers' ability to accurately predict and diagnose infection.
Ricardo Henao and team investigated natural language processing methods to identify patients with peripheral artery disease, offering a more effective alternative to the structured data-based approach.
Susanne Haga and Lori Orlando provide an overview of various risk assessment approaches and their benefits, limitations and implementation challenges.
Deepak Voora, T32 fellow Olivia Dong and team have been working on the Veterans Affairs Pharmacogenomic Testing for Veterans clinical program, which offers free, multi-gene pharmacogenomic (PGx) testing for 250,000 veterans over 5 years.
Chris Woods and team observed age-related variability in SARS-CoV-2 symptoms between children and adolescents, as well as Hispanic ethnicity and history of asthma playing a role in infection risk.
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.